AKER - Akers Bio down 45% after pricing equity offering December, 05 2019 10:35 AM Akers Biosciences Inc. Thinly traded nano cap Akers Biosciences (AKER -44.9%) slumps on a 76x surge in volume in response to its public offering of 1.99M units at $4/unit.More news on: Akers Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...